IntroductionOver the last few years, there has been an increase in the prevalence of <i>Blastocystis</i> spp. in colorectal cancer (CRC) patients. Moreover, various in vitro and in vivo studies have highlighted that intestinal colonisation of <i>Blastocystis</i> spp. has an influence on host immune responses leading to cellular apoptosis and membrane permeability. It has been suggested that <i>Blastocystis</i> spp. is an important risk factor for the worsening of CRC.AimTo present evidence concerning the association between CRC and <i>Blastocystis</i> spp.Material and methodsA review of the literature was performed by searching Science Direct, PubMed, Scopus and Google Scholar databases up to December, 2023.Results and discussionOut of all in vitro and in vivo studies selected for this review, the majority of them have confirmed a significantly higher prevalence of <i>Blastocystis</i> spp. in colorectal cancer patients in comparison to the control groups. Several in vitro human colorectal carcinoma cell line studies have shown significant cytopathic and immunological effects of <i>Blastocystis</i> spp. Additionally, in vivo experimental animal model studies have shown that <i>Blastocystis</i> spp. infection significantly contributed to large intestinal polyp (colorectal adenoma) formation and the progression of colorectal carcinogenesis.ConclusionsThese studies strongly support suggestions that <i>Blastocystis</i> spp. could be an important factor to existing CRC development by influencing the host immune response and increasing oxidative damage.
Read full abstract